Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.247
-0.002 (-0.96%)
Nov 21, 2024, 1:19 PM EST - Market open
Petros Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 3.89 | 13.34 | 9.43 | 23.85 | 17.14 | 2.15 | Upgrade
|
Cash & Short-Term Investments | 3.89 | 13.34 | 9.43 | 23.85 | 17.14 | 2.15 | Upgrade
|
Cash Growth | -78.33% | 41.49% | -60.47% | 39.14% | 698.75% | -23.20% | Upgrade
|
Accounts Receivable | 1.95 | 2.23 | 2.11 | 2.46 | 5.15 | 2.61 | Upgrade
|
Other Receivables | - | - | - | 0.61 | - | 1.55 | Upgrade
|
Receivables | 1.95 | 2.23 | 2.11 | 3.06 | 5.15 | 4.16 | Upgrade
|
Inventory | 3.05 | 2.79 | 1.82 | 0.52 | 0.76 | 2.2 | Upgrade
|
Prepaid Expenses | 1.83 | 1.22 | 0.51 | 1.58 | 1.37 | 1.56 | Upgrade
|
Other Current Assets | - | 0.82 | 0.8 | 1.53 | 1.48 | 2.02 | Upgrade
|
Total Current Assets | 10.72 | 20.39 | 14.67 | 30.54 | 25.91 | 12.09 | Upgrade
|
Property, Plant & Equipment | 0.14 | 0.26 | 0.4 | 0.52 | 0.64 | 0.74 | Upgrade
|
Other Intangible Assets | 6.83 | 8.97 | 12.24 | 25.29 | 32.16 | 38.81 | Upgrade
|
Other Long-Term Assets | 3 | 4.18 | 5.11 | 11.03 | 11.14 | 6.73 | Upgrade
|
Total Assets | 20.69 | 33.8 | 32.42 | 67.39 | 69.85 | 58.37 | Upgrade
|
Accounts Payable | 1.6 | 1.71 | 1.81 | 4.56 | 5.61 | 3.78 | Upgrade
|
Accrued Expenses | 8.28 | 3.23 | 1.32 | 3.5 | 2.96 | 7.92 | Upgrade
|
Current Portion of Long-Term Debt | 2.33 | 1.16 | 1.09 | - | 7.18 | 6.68 | Upgrade
|
Current Portion of Leases | - | 0.13 | 0.14 | 0.13 | 0.11 | 0.1 | Upgrade
|
Other Current Liabilities | 0.35 | 4.55 | 2.71 | 22.8 | 26.04 | 22.63 | Upgrade
|
Total Current Liabilities | 12.56 | 10.77 | 7.07 | 30.98 | 41.89 | 41.1 | Upgrade
|
Long-Term Debt | 4.92 | 6.86 | 8.39 | - | - | 7.06 | Upgrade
|
Long-Term Leases | - | 0.14 | 0.26 | 0.41 | 0.53 | 0.64 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 1.43 | Upgrade
|
Other Long-Term Liabilities | 0.09 | 3.55 | 0 | 0.46 | 9.96 | 0.11 | Upgrade
|
Total Liabilities | 17.58 | 21.32 | 15.72 | 31.85 | 52.38 | 50.35 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 29.12 | Upgrade
|
Additional Paid-In Capital | 107.05 | 110.96 | 107.43 | 106.23 | 79.17 | - | Upgrade
|
Retained Earnings | -103.93 | -98.89 | -90.73 | -70.69 | -61.7 | -41.12 | Upgrade
|
Total Common Equity | 3.12 | 12.07 | 16.7 | 35.54 | 17.47 | -12 | Upgrade
|
Shareholders' Equity | 3.12 | 12.48 | 16.7 | 35.54 | 17.47 | 8.02 | Upgrade
|
Total Liabilities & Equity | 20.69 | 33.8 | 32.42 | 67.39 | 69.85 | 58.37 | Upgrade
|
Total Debt | 7.25 | 8.28 | 9.88 | 0.53 | 7.81 | 14.48 | Upgrade
|
Net Cash (Debt) | -3.35 | 5.06 | -0.46 | 23.32 | 9.33 | -12.33 | Upgrade
|
Net Cash Growth | - | - | - | 150.05% | - | - | Upgrade
|
Net Cash Per Share | -0.55 | 2.33 | -0.22 | 21.41 | 17.46 | -50.13 | Upgrade
|
Filing Date Shares Outstanding | 10.01 | 6.88 | 2.09 | 2.07 | 0.98 | 3.43 | Upgrade
|
Total Common Shares Outstanding | 10.01 | 2.99 | 2.08 | 2.07 | 0.97 | 3.43 | Upgrade
|
Working Capital | -1.84 | 9.62 | 7.6 | -0.44 | -15.99 | -29.02 | Upgrade
|
Book Value Per Share | 0.31 | 4.04 | 8.03 | 17.18 | 18.00 | -3.49 | Upgrade
|
Tangible Book Value | -3.71 | 3.1 | 4.46 | 10.25 | -14.69 | -50.81 | Upgrade
|
Tangible Book Value Per Share | -0.37 | 1.04 | 2.14 | 4.96 | -15.13 | -14.79 | Upgrade
|
Machinery | - | - | - | - | - | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.